INTERNATIONAL BIOTECHNOLOGY TRUST PLC - GLOBUS MED INC ownership

GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 269 filers reported holding GLOBUS MED INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of GLOBUS MED INC
ValueSharesWeighting
Q4 2019$1,425,000
+15.2%
24,2000.0%0.51%
-10.3%
Q3 2019$1,237,000
+20.8%
24,2000.0%0.57%
+50.5%
Q2 2019$1,024,000
-14.4%
24,2000.0%0.38%
-14.0%
Q1 2019$1,196,000
+45.5%
24,2000.0%0.44%
-13.3%
Q4 2018$822,000
-34.9%
24,200
-16.6%
0.51%
-15.0%
Q3 2018$1,262,000
-13.7%
29,0000.0%0.60%
+6.8%
Q2 2018$1,463,000
+1.2%
29,0000.0%0.56%
-0.4%
Q1 2018$1,445,00029,0000.56%
Other shareholders
GLOBUS MED INC shareholders Q3 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 908,953$59,282,0005.54%
Sterling Investment Advisors, Ltd. 234,623$15,302,0005.20%
Next Capital Management LLC 111,098$7,246,0005.10%
Godshalk Welsh Capital Management, Inc. 77,085$5,027,0003.71%
Pembroke Management, LTD 613,931$40,041,0003.36%
XXEC, Inc. 52,800$3,444,0002.71%
Global Alpha Capital Management Ltd. 302,377$19,721,0002.42%
Van Berkom & Associates Inc. 1,572,303$102,546,0002.35%
PARADIGM CAPITAL MANAGEMENT INC/NY 581,700$37,939,0002.27%
RTW INVESTMENTS, LP 1,640,859$107,017,0001.80%
View complete list of GLOBUS MED INC shareholders